These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26977579)

  • 1. Adopting a Uniform Approach to Site Assignment in Tubo-Ovarian High-Grade Serous Carcinoma: The Time has Come.
    Singh N; Gilks CB; Hirshowitz L; Wilkinson N; McCluggage WG
    Int J Gynecol Pathol; 2016 May; 35(3):230-7. PubMed ID: 26977579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
    Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
    Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Fallopian Tube Origin and Primary Site Assignment in Extrauterine High-grade Serous Carcinoma: Findings of a Survey of Pathologists and Clinicians.
    McCluggage WG; Hirschowitz L; Gilks CB; Wilkinson N; Singh N
    Int J Gynecol Pathol; 2017 May; 36(3):230-239. PubMed ID: 27801755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of fallopian tube and decrease of ovarian carcinoma: fact or fake?
    Höhn AK; Klagges S; Gläser A; Taubenheim S; Dornhöfer N; Einenkel J; Hiller GGR; Brambs CE; Horn LC
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):911-925. PubMed ID: 32915262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease Distribution in Low-stage Tubo-ovarian High-grade Serous Carcinoma (HGSC): Implications for Assigning Primary Site and FIGO Stage.
    Singh N; Benson JL; Gan C; Anglesio M; Arora R; Faruqi AZ; Hirschowitz L; Kommoss F; Scott K; Trevisan G; Leen SLS; Wilkinson N; Gilks CB; McCluggage WG
    Int J Gynecol Pathol; 2018 Jul; 37(4):324-330. PubMed ID: 28787323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift.
    Reade CJ; McVey RM; Tone AA; Finlayson SJ; McAlpine JN; Fung-Kee-Fung M; Ferguson SE
    J Obstet Gynaecol Can; 2014 Feb; 36(2):133-140. PubMed ID: 24518912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Stage High-Grade Serous Ovarian Carcinomas: Support for an Extraovarian Origin.
    Morency E; Leitao MM; Soslow RA
    Int J Gynecol Pathol; 2016 May; 35(3):222-9. PubMed ID: 26630225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of a new system for primary site assignment in high-grade serous carcinoma of the fallopian tube, ovary, and peritoneum.
    Singh N; Gilks CB; Wilkinson N; McCluggage WG
    Histopathology; 2015 Sep; 67(3):331-7. PubMed ID: 25640750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas.
    Gilks CB; Irving J; Köbel M; Lee C; Singh N; Wilkinson N; McCluggage WG
    Am J Surg Pathol; 2015 Mar; 39(3):357-64. PubMed ID: 25517954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-grade serous carcinoma of tubo-ovarian origin: recent developments.
    Singh N; McCluggage WG; Gilks CB
    Histopathology; 2017 Sep; 71(3):339-356. PubMed ID: 28477361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The secondary Müllerian system, field effect, BRCA, and tubal fimbria: our evolving understanding of the origin of tubo-ovarian high-grade serous carcinoma and why assignment of primary site matters.
    Singh N; Gilks CB; Wilkinson N; McCluggage WG
    Pathology; 2015 Aug; 47(5):423-31. PubMed ID: 26126051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically occult tubal and ovarian high-grade serous carcinomas presenting in uterine samples: diagnostic pitfalls and clues to improve recognition of tumor origin.
    Bagby C; Ronnett BM; Yemelyanova A; Maleki Z; Kuhn E; Vang R
    Int J Gynecol Pathol; 2013 Sep; 32(5):433-43. PubMed ID: 23896706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assignment of primary site in high-grade serous tubal, ovarian and peritoneal carcinoma: a proposal.
    Singh N; Gilks CB; Wilkinson N; McCluggage WG
    Histopathology; 2014 Aug; 65(2):149-54. PubMed ID: 24660659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the fallopian tube in ovarian cancer.
    Tone AA; Salvador S; Finlayson SJ; Tinker AV; Kwon JS; Lee CH; Cohen T; Ehlen T; Lee M; Carey MS; Heywood M; Pike J; Hoskins PJ; Stuart GC; Swenerton KD; Huntsman DG; Gilks CB; Miller DM; McAlpine JN
    Clin Adv Hematol Oncol; 2012 May; 10(5):296-306. PubMed ID: 22706539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.
    Vang R; Shih IeM; Kurman RJ
    Histopathology; 2013 Jan; 62(1):44-58. PubMed ID: 23240669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiles of ovarian low-grade serous carcinoma resemble those of fallopian tube epithelium.
    Qiu C; Lu N; Wang X; Zhang Q; Yuan C; Yan S; Dongol S; Li Y; Sun X; Sun C; Zhang Z; Zheng W; Kong B
    Gynecol Oncol; 2017 Dec; 147(3):634-641. PubMed ID: 28965696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Fallopian tube odyssey: from the ovary to the tube. About high-grade serous ovarian carcinoma].
    Chêne G; Dauplat J; Radosevic-Robin N; Cayre A; Penault-Llorca F
    Bull Cancer; 2013; 100(7-8):757-64. PubMed ID: 23831931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
    Wen J; Shi JL; Shen DH; Chen YX; Song QJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma].
    Liang Y; Chen XD; Lü BJ; Zhou CY; Zhang XF; Shi HY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):724-8. PubMed ID: 22321343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do deeper sections increase the frequency of detection of serous tubal intraepithelial carcinoma (STIC) in the "sectioning and extensively examining the FIMbriated end" (SEE-FIM) protocol?
    Mahe E; Tang S; Deb P; Sur M; Lytwyn A; Daya D
    Int J Gynecol Pathol; 2013 Jul; 32(4):353-7. PubMed ID: 23722507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.